|

ADT with Luteinizing hormone-releasing hormone (LHRH) analog Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • Metastatic Castration-resistant Prostate Cancer1
  • Cancer1

Tampa, Florida1 trial

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.